The biological activity of IL-17A is measured by its ability to stimulate IL-6 production in NIH/3T3 mouse embryonic fibroblast cells. The ED50, which represents the concentration of IL-17A required to achieve half-maximal IL-6 production, is within the range of ≤7 ng/ml. IL-6 levels are determined using an enzyme-linked immunosorbent assay (ELISA).
Interleukin 17A (IL-17A) is a proinflammatory cytokine produced by activated T cells. It plays a crucial role in the immune response by regulating the activities of NF-kappaB and mitogen-activated protein kinases. IL-17A can stimulate the expression of IL-6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of IL-17A are associated with several chronic inflammatory diseases, including rheumatoid arthritis, psoriasis, and multiple sclerosis .
The recombinant form of IL-17A, produced in Sf9 Baculovirus cells, is a single, glycosylated polypeptide chain containing 138 amino acids and having a molecular mass of 15.9 kDa. This form of IL-17A is fused to a 6 amino acid His Tag at the C-terminus. The protein shows multiple bands between 13.5-28 kDa on SDS-PAGE under reducing conditions and is purified using proprietary chromatographic techniques .
IL-17A is known for its proinflammatory properties. It regulates the activities of NF-kappaB and mitogen-activated protein kinases, stimulates the expression of IL-6 and cyclooxygenase-2 (PTGS2/COX-2), and enhances the production of nitric oxide (NO). These activities make IL-17A a key player in the immune response and inflammation .
IL-17A protein solution should be stored at 4°C if it will be used within 2-4 weeks. For longer periods, it should be stored frozen at -20°C. For long-term storage, it is recommended to add a carrier protein (0.1% HSA or BSA) to avoid multiple freeze-thaw cycles. The protein is stable and maintains its biological activity under these storage conditions .